Stericycle, Inc. (NASDAQ: SRCL) recently received the rating of “Hold” after a consensus from analysts of twelve brokerages covering this stock.
Among the twelve analysts’ ratings, one has given out a rating of “Sell”, five have rated it as “Hold” and another five brokerages have rated the company as “Buy”. The 52-week target price as set by these brokerages stand at $64.40.
SRCL stocks traded at $69.72 this Friday. The company’ current market capitalization stands at $6.38 billion. It has a negative PE ratio of 20.94 along with a beta of 1.20 at the moment. The 12-monthly high to low ranges from $79.50 to $38.45. The 50SMA (50 Days Simple Moving Average) stands at $70.78 and its 200SMA stands at $63.86. The debt-to-equity of this company is 0.87. The current ratio stands at 0.90 and the quick ratio stands at 0.90.
Stericycle, Inc. (NASDAQ: SRCL) Stock Analysis
The quarterly earnings report for the previous quarter was released on the 5th of November. The earnings stood at $0.68 EPS as opposed to the general consensus of $0.57 proposed by several equities’ analysts. The company’s return on equity stands at 9.73% along with the net margin of 10.05%. The estimated income for the firm was marked at $640.63 million but it made $636.40 million for the quarter.
During the corresponding quarter previous year, the company reported $0.80 as EPS. According to the available data, the company’s revenue is 23.6% down on a y-o-y basis. Expert analysts further expect that the company will post its FY2020 earnings of 2.14 per share.
NASDAQ: SRCL has recently been the subject of a lot of reports by research analysts. Some such as Berenberg Bank, Raymond James, BidAskClub, BMO Capital Markets, and so on have posted reports on this company over the last few months. Several hedge funds and institutional investors have also been involved in buying and selling of SRCL shares recently.